
Labfarmsp. z o.o.
Research and experimental development in natural sciences and engineering
Overview
Labfarm brings together bioengineers, scientists and business professionals to develop meat grown from animal cells. The company is working on meat production without slaughter, using bioreactors and cell-culturing technology.
Financials
Revenue history
Filing timeliness
1 of 4 financial statements was filed late (for 2025, 2 days late).
- 202517/07/2026
- 202411/07/2025
- 202315/07/2024
- 202213/07/2023
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board, one member of the management board acting independently is authorized to make declarations of will on behalf of the company. In the case of a multi-member management board, each member of the management board is authorized to make declarations of will on behalf of the company independently up to the amount of PLN 20,000, and above that amount, joint action by two members of the management board is required.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Fundacja Rodzinna A. Krzyżanowska | 195 | $2,633.71 | 19.5% |
Fundacja Rodzinna J. Krzyżanowski | 305 | $4,119.39 | 30.5% |
Stanisław Łoboziakage 40 | 250 | $3,376.55 | 25% |
Wiesław Macherzyńskiage 48 | 250 | $3,376.55 | 25% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2022-07-16.
51 1090 1056 0000 0001 4942 4426
24 1090 1056 0000 0001 4942 4427
81 1090 1056 0000 0001 4942 4468
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 26, 2025 | Aid for research and development projects: industrial research | $2M$2,008,066 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Mar 26, 2025 | Aid for research and development projects: experimental development | $272.2K$272,154 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2024-11-01 | Development of a new product – cultured meat – together with an innovative production technology. | $2.3M$2,275,078 | European Funds for a Modern Economy |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| NanotheaS.A. | $115.78 | nanothea.com | ||
| Alsitechsp. z o.o. | $105.39 | alsitech.pl | ||
| Genovaris Medicalsp. z o.o. | $25.11 | genovaris.com |
Change history
| Date | Event | |
|---|---|---|
| 2024-11-04 | Share capital increase (20,000.00 PLN → 50,000.00 PLN) | |
| 2022-02-03 | Entered in the register |
FAQ
Last updated: 2026-10-04